Comparison Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 20/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 56.51 USD | +3.27% |
|
+8.53% | +28.29% |
| 10/08 | Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date | MT |
| 10/08 | Novo Nordisk works to address FDA's findings at Indiana plant | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Bio Therapeutic Drugs | +3.27% | +8.53% | +28.29% | +79.28% | +33.88% | 666.41Cr |
- Stock Market
- Stocks
- SRRK Stock
- Charts Scholar Rock Holding Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















